Терапевтические подходы к ведению женщин с гестационной артериальной гипертензией: взгляд кардиолога

Abstract

The need to expand knowledge about the early stages of gestational therapy for pregnant women with hypertensive disorders is driven by several factors. First, the selection of the optimal antihypertensive therapy regimen is limited by the feasibility of conducting large-scale studies in representative populations due to time constraints and the responsibility for the life of not only the mother but also the child. Second, current recommendations generally recommend initiating therapy by titrating a single drug regardless of blood pressure levels, limiting the use of combination regimens. Third, the identification of specific cardiac risks is limited by the timely implementation of an effective screening strategy.

Topics

Identifiers

DOI

10.70626/cardiouz-2025-2-00072

Citations and references